Monoamine oxidase and cigarette smoking

Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis

Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914 · see citing works

THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE

Schildkraut, J. J. (1965) · American Journal of Psychiatry · doi:10.1176/ajp.122.5.509 · Cited by 3,499 · see citing works

Some observations upon a new inhibitor of monoamine oxidase in brain tissue

Johnston, J. P. (1968) · Biochemical Pharmacology · doi:10.1016/0006-2952(68)90066-x · Cited by 1,597 · see citing works

MONOAMINE OXIDASE: From Genes to Behavior

Shih, J. C., Chen, K., & Ridd, M. J. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.197 · Cited by 1,211 · see citing works

Smoking, smoking cessation, and major depression

Glassman, A. H. (1990) · JAMA · doi:10.1001/jama.1990.03450120058029 · Cited by 1,207 · see citing works

Prevalence of smoking among psychiatric outpatients

(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.8.993 · Cited by 1,058 · see citing works

Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors

Heikkila, R. E., Manzino, L., Cabbat, F. S., & Duvoisin, R. C. (1984) · Nature · doi:10.1038/311467a0 · Cited by 1,010 · see citing works

Pharmacologic Aspects of Cigarette Smoking and Nicotine Addiction

Oates, J. A., Wood, A. J. J., & Benowitz, N. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198811173192005 · Cited by 963 · see citing works

cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties.

Bach, A. W., Lan, N. C., Johnson, D. L., Abell, C. W., Bembenek, M. E., Kwan, S. W., SEEBURG, P. H., & Shih, J. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.13.4934 · Cited by 725 · see citing works

Inhibition of monoamine oxidase B in the brains of smokers

Fowler, J. S., Volkow, N. D., Wang, G., Pappas, N. R., Logan, J., MacGregor, R. R., Alexoff, D. L., Shea, C. E., Schlyer, D. J., Wolf, A. P., et al. (1996) · Nature · doi:10.1038/379733a0 · Cited by 657 · see citing works

The Effect of Deprenyl (Selegiline) on the Natural History of Parkinson's Disease

Tetrud, J. W., & Langston, J. W. (1989) · Science · doi:10.1126/science.2502843 · Cited by 635 · see citing works

Pargyline Prevents MPTP-Induced Parkinsonism in Primates

Langston, J. W., Irwin, I., Langston, E. B., & Forno, L. S. (1984) · Science · doi:10.1126/science.6332378 · Cited by 581 · see citing works

Some puzzling pharmacological effects of monoamine oxidase inhibitors.

Knoll, J. E., & Magyar, K. (1972) · PubMed · Cited by 560 · see citing works

Brain monoamine oxidase A inhibition in cigarette smokers

Fowler, J. S., Volkow, N. D., Wang, G., Pappas, N. R., Logan, J., Shea, C. E., Alexoff, D. L., MacGregor, R. R., Schlyer, D. J., Zezulkova, I., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14065 · Cited by 423 · see citing works

Mapping Human Brain Monoamine Oxidase A and B with11C-Labeled Suicide Inactivators and PET

Fowler, J. S., MacGregor, R. R., Wolf, A. P., Arnett, C. D., Dewey, S. L., Schlyer, D. J., Christman, D. R., Logan, J., Smith, M. R., Sachs, H., et al. (1987) · Science · doi:10.1126/science.3099392 · Cited by 389 · see citing works

The Biochemical High-Risk Paradigm: Behavioral and Familial Correlates of Low Platelet Monoamine Oxidase Activity

Buchsbaum, M. S., Coursey, R. D., & Murphy, D. L. (1976) · Science · doi:10.1126/science.968488 · Cited by 377 · see citing works

Smoking cessation and the course of major depression: A follow-up study

Glassman, A. H., Covey, L. S., Stetner, F., & Rivelli, S. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05064-9 · Cited by 370 · see citing works

Cigarette smoking and protection from Parkinson's disease

Morens, D. M., Grandinetti, A., REED, D. M., White, L. R., & Ross, G. W. (1995) · Neurology · doi:10.1212/wnl.45.6.1041 · Cited by 368 · see citing works

Parkinson disease: A new link between monoamine oxidase and mitochondrial electron flow

Cohen, G., Farooqui, R., & Kesler, N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.4890 · Cited by 286 · see citing works

Tyramine oxidase

Hare, M. L. C. (1928) · Biochemical Journal · doi:10.1042/bj0220968 · Cited by 283 · see citing works

Smoking, smoking cessation, and major depression

Glassman, A. H. (1990) · JAMA · doi:10.1001/jama.264.12.1546 · Cited by 251 · see citing works

Differences in Platelet Enzyme Activity between Alcoholics and Nonalcoholics

Tabakoff, B., Hoffman, P. L., Lee, J. M., Saito, T., Willard, B., & DeLeon-Jones, F. A. (1988) · New England Journal of Medicine · doi:10.1056/nejm198801213180302 · Cited by 244 · see citing works

Involvement of tobacco in alcoholism and illicit drug use

Henningfield, J. E., Clayton, R., & Pollin, W. (1990) · British Journal of Addiction · doi:10.1111/j.1360-0443.1990.tb03084.x · Cited by 240 · see citing works

Dose‐related neuroprotective effects of chronic nicotine in 6‐hydroxydopamine treated rats, and loss of neuroprotection in α4 nicotinic receptor subunit knockout mice

Ryan, R. E., Ross, S. A., Drago, J., & Loiacono, R. E. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703989 · Cited by 188 · see citing works

AMINE OXIDASES

Zeller, E. A., Barsky, J., & Berman, E. R. (1955) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)70965-4 · Cited by 184 · see citing works

Über den enzymatischen Abbau von Histamin und Diaminen. 2. Mitteilung

Zeller, E. A. (1938) · Helvetica Chimica Acta · doi:10.1002/hlca.193802101115 · Cited by 170 · see citing works

High Levels of Dopamine Activity in the Basal Ganglia of Cigarette Smokers

Salokangas, R. K. R., Vilkman, H., Ilonen, T., Taiminen, T., Bergman, J., Haaparanta, M., Solin, O., Alanen, A., Syvã«¡hti, E., & Hietala, J. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.4.632 · Cited by 164 · cited 2× · see citing works

Selective reduction of radiotracer trapping by deuterium substitution: comparison of carbon-11-L-deprenyl and carbon-11-deprenyl-D2 for MAO B mapping.

Fowler, J. S., Wang, G., Logan, J., Xie, S., Volkow, N. D., MacGregor, R. R., Schlyer, D. J., Pappas, N. R., Alexoff, D. L., & Patlak, C. S. (1995) · PubMed · Cited by 163 · see citing works

A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers*

Berlin, I., Saïd, S., Spreux‐Varoquaux, O., Launay, J., Olivares, R., Millet, V., Lecrubier, Y., & Puech, A. J. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90058-6 · Cited by 157 · see citing works

The inactivation of adrenaline

Blaschko, H. K. F., Richter, D., & Schloßmann, H. (1937) · The Journal of Physiology · doi:10.1113/jphysiol.1937.sp003497 · Cited by 151 · see citing works

Slow recovery of human brain MAO B after L‐Deprenyl (Selegeline) withdrawal

Fowler, J. S., Volkow, N. D., Logan, J., Wang, G., Gregor, R. R. M., Schlyer, D. J., Wolf, A. P., Pappas, N. R., Alexoff, D. L., Shea, C. E., et al. (1994) · Synapse · doi:10.1002/syn.890180203 · Cited by 147 · see citing works

Monoamine oxidases and tobacco smoking

Berlin, I., & Anthenelli, R. M. (2001) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145701002188 · Cited by 146 · see citing works

Monoamine oxidase A and B activities in heavy smokers

Berlin, I., Saïd, S., Spreux‐Varoquaux, O., Olivares, R., Launay, J., & Puech, A. J. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00084-4 · Cited by 131 · see citing works

Low platelet monoamine oxidase activity in cigarette smokers

Oreland, L., Fowler, C. J., & Schalling, D. (1981) · Life Sciences · doi:10.1016/0024-3205(81)90706-2 · Cited by 128 · see citing works

TREATMENT OF PULMONARY TUBERCULOSIS WITH HYDRAZIDE DERIVATIVES OF ISONICOTINIC ACID

Selikoff, I. J. (1952) · JAMA · doi:10.1001/jama.1952.03680100015006 · Cited by 124 · see citing works

Platelet Mao Activity and Evoked Potentials in the Identification of Subjects Biologically at Risk for Psychiatric Disorders

Coursey, R. D., Buchsbaum, M. S., & Murphy, D. L. (1979) · The British Journal of Psychiatry · doi:10.1192/bjp.134.4.372 · Cited by 123 · see citing works

Irreversible inhibition of monoamine oxidase by some components of cigarette smoke

Yu, P. H., & Boulton, A. A. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90446-2 · Cited by 122 · see citing works

Low platelet monoamine oxidase activity in human alcoholics.

Wiberg, Å., Gottfries, C. G., & Oreland, L. (1977) · PubMed · Cited by 111 · see citing works

Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): a dose ranging study with the reversible inhibitor Ro 19-6327

Bench, C. J., Price, G. W., Lammertsma, A. A., Cremer, J., Luthra, S. K., Turton, D. R., Dolan, R. J., Kettler, R., Dingemanse, J., Prada, M. D., et al. (1991) · European Journal of Clinical Pharmacology · doi:10.1007/bf00280072 · Cited by 105 · see citing works

THE PSYCHIATRIC SIDE-EFFECTS OF IPRONIAZID

Crane, G. E. (1956) · American Journal of Psychiatry · doi:10.1176/ajp.112.7.494 · Cited by 99 · see citing works

Isolation and Characterization of a Monoamine Oxidase Inhibitor from Tobacco Leaves

Khalil, A. A., Steyn, S., & Castagnoli, N. (1999) · Chemical Research in Toxicology · doi:10.1021/tx990146f · Cited by 98 · see citing works

Smoking and Parkinson's disease: a case-control study in Germany

Hellenbrand, W., Seidler, A., Robra, B., Vieregge, P., Oertel, W. H., Joerg, J., NISCHAN, P., Schneider, E., & Ulm, G. (1997) · International Journal of Epidemiology · doi:10.1093/ije/26.2.328 · Cited by 87 · see citing works

Platelet Monoamine Oxidase Activity in Subgroups of Alcoholics and Controls: Results from the Collaborative Study on the Genetics of Alcoholism

Anthenelli, R. M., TIPP, J. E., Li, T., Magnes, L., Schuckit, M. A., Rice, J. P., Daw, W., & Nürnberger, J. I. (1998) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb04298.x · Cited by 81 · see citing works

Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms

Behm, F. M., Rose, J. E., Ramsey, C., & Ritchie, J. C. (2001) · Nicotine & Tobacco Research · doi:10.1080/14622200110087277 · Cited by 72 · see citing works

Clinical Pharmacology of Monoamine Oxidase Inhibitors

McDaniel, K. D. (1986) · Clinical Neuropharmacology · doi:10.1097/00002826-198606000-00001 · Cited by 70 · see citing works

Monoamine oxidases: old friends hold many surprises

Singer, T. P., & Ramsay, R. R. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.8.7768351 · Cited by 69 · see citing works

Platelet monoamine oxidase: Low activity in cigarette smokers

Norman, T. R., Chamberlain, K. G., & French, M. A. (1987) · Psychiatry Research · doi:10.1016/0165-1781(87)90079-5 · Cited by 69 · see citing works

Maintenance of Brain Monoamine Oxidase B Inhibition in Smokers After Overnight Cigarette Abstinence

Fowler, J. S., Wang, G., Volkow, N. D., Franceschi, D., Logan, J., Pappas, N. R., Shea, C. E., MacGregor, R. R., & Garza, V. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.11.1864 · Cited by 68 · see citing works

Dopamine induces ERK activation in renal epithelial cells through H2O2 produced by monoamine oxidase

Vindis, C., Séguélas, M., Lanier, S. M., Parini, A., & Cambon, C. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00468.x · Cited by 67 · see citing works

Personality traits and platelet monoamine oxidase in tobacco smokers

von Knorring, L., & Oreland, L. (1985) · Psychological Medicine · doi:10.1017/s0033291700023606 · Cited by 67 · see citing works

Association of monoamine oxidase (MAO) activity with alcoholism and alcoholic subtypes

Devor, E. J., Cloninger, C. R., Hoffman, P. L., & Tabakoff, B. (1993) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320480407 · Cited by 66 · see citing works

Pharmacogenetics and Ethnoracial Differences in Smoking

Sellers, E. M. (1998) · JAMA · doi:10.1001/jama.280.2.179 · Cited by 63 · see citing works

Platelet monoamine oxidase activity and cigarette smoking

Norman, T. R., Chamberlain, K. G., French, M. A., & Burrows, G. D. (1982) · Journal of Affective Disorders · doi:10.1016/0165-0327(82)90021-0 · Cited by 61 · see citing works

Monoamine oxidase B, smoking, and Parkinson's disease

Yong, V. W., & Perry, T. L. (1986) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(86)90014-6 · Cited by 59 · see citing works

MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD

Hernán, M. Á., Checkoway, H., O’Brien, R., Costa‐Mallen, P., Vivo, I. D., Colditz, G. A., Hunter, D. J., Kelsey, K. T., & Ascherio, A. (2002) · Neurology · doi:10.1212/wnl.58.9.1381 · Cited by 59 · see citing works

Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by tobacco smoke

Carr, L. A., & Rowell, P. P. (1990) · Neuropharmacology · doi:10.1016/0028-3908(90)90019-n · Cited by 58 · see citing works

Neuroprotection in the MPTP Parkinsonian C57BL/6 Mouse Model by a Compound Isolated from Tobacco

Castagnoli, K., Steyn, S. J., Petzer, J. P., der Schyf, C. J. V., & Castagnoli, N. J. (2001) · Chemical Research in Toxicology · doi:10.1021/tx000224v · Cited by 57 · see citing works

2-Naphthylamine, a compound found in cigarette smoke, decreases both monoamine oxidase A and B catalytic activity

Hauptmann, N., & Shih, J. C. (2001) · Life Sciences · doi:10.1016/s0024-3205(00)01022-5 · Cited by 52 · see citing works

Dopamine metabolism and neurotransmission in primate brain in relationship to monoamine oxidase A and B inhibition

Youdim, M. B. H., & Riederer, P. F. (1993) · Journal of Neural Transmission · doi:10.1007/bf01245231 · Cited by 52 · see citing works

Smoking a single cigarette does not produce a measurable reduction in brain MAO B in non-smokers

Fowler, J. S., Wang, G., Volkow, N. D., Franceschi, D., Logan, J., Pappas, N. R., Shea, C. E., MacGregor, R. R., & Garza, V. (1999) · Nicotine & Tobacco Research · doi:10.1080/14622299050011451 · Cited by 49 · see citing works

Effects of tobacco smoke constituents on MPTP-induced toxicity and monoamine oxidase activity in the mouse brain

Carr, L. A., & Basham, J. K. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90455-k · Cited by 49 · see citing works

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity: partial protection against striato-nigral dopamine depletion in C57BL/6J mice by cigarette smoke exposure and by β-naphthoflavone-pretreatment

Shahi, G. S., Das, N. P., & Moochhala, S. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90804-3 · Cited by 47 · see citing works

An acute dose of nicotine does not inhibit MAO B in baboon brain in vivo

Fowler, J. S., Volkow, N. D., Logan, J., Pappas, N. R., King, P. T., MacGregor, R. R., Shea, C. E., Garza, V., & Gatley, S. J. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00251-3 · Cited by 41 · see citing works

Platelet MAO activity in subtypes of alcoholics and controls in a homogenous population

Farren, C. K., Clare, A. W., Tipton, K. F., & Dinan, T. G. (1998) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(98)00047-8 · Cited by 36 · see citing works

Effects of past history of major depression on smoking characteristics, monoamine oxidase-A and -B activities and withdrawal symptoms in dependent smokers

Berlin, I., Spreux‐Varoquaux, O., Saïd, S., & Launay, J. (1997) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(97)01338-0 · Cited by 33 · see citing works

Low platelet monoamine oxidase activity in Swedish imprisoned criminal offenders

Garpenstrand, H. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(01)00148-1 · Cited by 33 · see citing works

Schizophrenia, Monoamine Oxidase Activity, and Cigarette Smoking

Simpson, G. M. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00119-5 · Cited by 32 · see citing works

Studies on the interaction between 1,2,3,4-tetrahydro-β-carboline and cigarette smoke: a potential mechanism of neuroprotection for Parkinson's disease

Soto‐Otero, R., Méndez‐Álvarez, E., Riguera, R., Quiñoá, E., Sánchez‐Sellero, I., & López‐Rivadulla, M. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00538-1 · Cited by 29 · see citing works

The correlation between platelet MAO activity and personality--the effect of smoking and possible mechanisms behind the correlation.

Oreland, L., Garpenstrand, H., Damberg, M., Alm, P. O., Thorell, L. H., af Klinteberg, B., & Ekblom, J. (1999) · PubMed · Cited by 25 · see citing works

Monoamine oxidases: from brain maps to physiology and transgenics to pathophysiology

Richards, J. G., Saura, J., Luque, J. M., Cesura, A. M., Gottowik, J., Malherbe, P., Borroni, E., & Gray, J. A. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6499-0_17 · Cited by 25 · see citing works

Platelet monoamine oxidase B activity is inversely associated with plasma cotinine concentration

Berlin, I. (2000) · Nicotine & Tobacco Research · doi:10.1080/14622200050147501 · Cited by 24 · see citing works

Serotonin and monoamine oxidase in mouse skin: effects of cigarette smoke exposure.

Essman, W. B. (1977) · PubMed · Cited by 22 · see citing works

Low platelet monoamine oxidase activity in Swedish imprisoned criminal offenders : European Neuropsychopharmacology

Garpenstrand, H., Longato-Stadler, E., af Klinteberg, B., Grigorenko, E. L., Damberg, M., Oreland, L., & Hallman, J. (2002) · European Neuropsychopharmacology · Cited by 6 · see citing works

Endoprótesis metálicas en territorio ilíaco: seguimiento a largo plazo

Pérez, R. R., Villamor, J. M. C., Moreno, M. D. P., Anllo, M. H., & Moliner, M. M. (1996) · The American Journal of Human Genetics · Cited by 3 · see citing works

Nicotine addiction

Benowitz, N. L. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0809890 · Cited by 1,508 · see citing works

Imaging dopamine's role in drug abuse and addiction

Volkow, N. D., Fowler, J. S., Wang, G. J., Baler, R., & Telang, F. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.05.022 · Cited by 988 · see citing works

Drug addiction: the neurobiology of behaviour gone awry

Volkow, N. D., & Li, T. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1539 · Cited by 620 · see citing works

Sensation Seeking And Risky Behavior

Zuckerman, M. (2006) · Choice Reviews Online · doi:10.5860/choice.45-2321 · Cited by 815 · see citing works

Estimating the Harms of Nicotine-Containing Products Using the MCDA Approach

Nutt, D., Phillips, L. D., Balfour, D. J. K., Curran, H. V., Dockrell, M. J., Foulds, J., Fagerström, K. O., Letlape, K., Milton, A., Polosa, R., et al. (2014) · European Addiction Research · doi:10.1159/000360220 · Cited by 439 · see citing works

β-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO)

Herraiz, T., González, D., Ancín-Azpilicueta, C., Arán, V. J., & Guillén, H. (2010) · Food and Chemical Toxicology · doi:10.1016/j.fct.2009.12.019 · Cited by 357 · see citing works

Imaging the Addicted Human Brain

Fowler, J. S., Volkow, N. D., Kassed, C. A., & Chang, L. (2007) · Science & Practice Perspectives · doi:10.1151/spp07324 · Cited by 304 · see citing works

Human monoamine oxidase is inhibited by tobacco smoke: β-carboline alkaloids act as potent and reversible inhibitors

Herraiz, T., & Chaparro, C. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.033 · Cited by 258 · see citing works

Nicotine and brain development

Dwyer, J. B., Broide, R. S., & Leslie, F. M. (2008) · Birth Defects Research Part C: Embryo Today: Reviews · doi:10.1002/bdrc.20118 · Cited by 256 · see citing works

Genome-Wide and Candidate Gene Association Study of Cigarette Smoking Behaviors

Caporaso, N. E., Gu, F., Chatterjee, N., Jin, S. C., Yu, K., Yeager, M., Chen, C., Jacobs, K. B., Wheeler, W., Landi, M. T., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004653 · Cited by 246 · see citing works

Smoking and suicide: A brief overview

Hughes, J. R. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.06.003 · Cited by 236 · see citing works

The vascular effects of trace amines and amphetamines

Broadley, K. J. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.11.005 · Cited by 214 · see citing works

The reality of comorbidity: Depression and drug abuse

Volkow, N. D. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.007 · Cited by 213 · see citing works

Functional brain imaging of tobacco use and dependence

BRODY, A. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.04.012 · Cited by 207 · see citing works

A twin registry study of the relationship between posttraumatic stress disorder and nicotine dependence in men

Koenen, K. C., Hitsman, B., Lyons, M. J., Niaura, R., McCaffery, J., Goldberg, J., Eisen, S. A., True, W., & Tsuang, M. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.11.1258 · Cited by 197 · see citing works

Abuse Liability Assessment of Tobacco Products Including Potential Reduced Exposure Products

Carter, L. P., Stitzer, M. L., Henningfield, J. E., O'Connor, R. J., Cummings, K. M., & Hatsukami, D. K. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0948 · Cited by 115 · see citing works

Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature

Philip, N. S., Carpenter, L. L., Tyrka, A. R., & Price, L. H. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1932-6 · Cited by 185 · see citing works

Monoamine Oxidase Expression During Development and Aging

Nicotra, A. (2003) · NeuroToxicology · doi:10.1016/s0161-813x(03)00095-0 · Cited by 181 · see citing works

Smoking and the Risk of Suicidal Behavior: A Prospective Study of a Community Sample

Breslau, N., Schultz, L. R., Johnson, E. O., Peterson, E. L., & Davis, G. C. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.3.328 · Cited by 175 · see citing works

Tobacco addiction and the dysregulation of brain stress systems

Bruijnzeel, A. W. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.02.015 · Cited by 172 · see citing works

Gateway effects and electronic cigarettes

Etter, J. (2017) · Addiction · doi:10.1111/add.13924 · Cited by 172 · see citing works

Monoamine oxidase and tobacco dependence.

Lewis, A., Miller, J. H., & Lea, R. A. (2007) · Neurotoxicology · doi:10.1016/j.neuro.2006.05.019 · Cited by 153 · see citing works

Role of acetaldehyde in tobacco smoke addiction

Talhout, R., Opperhuizen, A., & van Amsterdam, J. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.02.013 · Cited by 145 · see citing works

Human monoamine oxidase enzyme inhibition by coffee and β-carbolines norharman and harman isolated from coffee

Herraiz, T., & Chaparro, C. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.074 · Cited by 141 · see citing works

Epidemiologic studies of environmental exposures in Parkinson's disease

Elbaz, A., & Tranchant, C. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.06.024 · Cited by 135 · see citing works

New Pyrrole Inhibitors of Monoamine Oxidase: Synthesis, Biological Evaluation, and Structural Determinants of MAO-A and MAO-B Selectivity

Regina, G. L., Silvestri, R., Artico, M., Lavecchia, A., Novellino, E., Befani, O., Turini, P., & Agostinelli, E. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm060882y · Cited by 126 · see citing works

Effects of progression to cigarette smoking on depressed mood in adolescents: evidence from the National Longitudinal Study of Adolescent Health

Munafo, M. R., Hitsman, B. L., Rende, R., Metcalfe, C. D., & NIAURA, R. S. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.02052.x · Cited by 123 · see citing works

Untitled work

(2009) · PubMed · Cited by 116 · see citing works

Platelet Monoamine Oxidase, Personality and Alcoholism: The Rise, Fall and Resurrection

Oreland, L. (2003) · NeuroToxicology · doi:10.1016/s0161-813x(03)00115-3 · Cited by 113 · see citing works

Nicotine reduction revisited: science and future directions

Hatsukami, D. K., Perkins, K. A., LeSage, M. G., Ashley, D. L., Henningfield, J. E., Benowitz, N. L., Backinger, C. L., & Zeller, M. (2010) · Tobacco Control · doi:10.1136/tc.2009.035584 · Cited by 109 · see citing works

Smoking predicts posttraumatic stress symptoms among rescue workers: a prospective study of ambulance personnel involved in the Enschede Fireworks Disaster

van der Velden, P. G., Kleber, R. J., & Koenen, K. C. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.11.001 · Cited by 108 · see citing works

Advances in pharmacotherapy for tobacco dependence

Foulds, J., Burke, M. V., Steinberg, M. B., Williams, J. M., & Ziedonis, D. M. (2004) · Expert Opinion on Emerging Drugs · doi:10.1517/eoed.9.1.39.32951 · Cited by 107 · see citing works

Imbalance between drug and non-drug reward availability: A major risk factor for addiction

Ahmed, S. H. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.09.036 · Cited by 104 · see citing works

New mechanisms and perspectives in nicotine withdrawal

Jackson, K. J., Muldoon, P. P., Biasi, M. D., & Damaj, M. I. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.009 · Cited by 103 · see citing works

Smoking predicts suicidality: Findings from a prospective community study

Bronisch, T., Höfler, M., & Lieb, R. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.10.010 · Cited by 99 · see citing works

The Neuronal Pathways Mediating the Behavioral and Addictive Properties of Nicotine

Balfour, D. J. K. (2009) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-69248-5_8 · Cited by 99 · see citing works

Rodent models of nicotine reward: What do they tell us about tobacco abuse in humans?

O’Dell, L. E., & Khroyan, T. V. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.12.011 · Cited by 95 · see citing works

Genetics of nicotine dependence and pharmacotherapy

Lessov‐Schlaggar, C. N., Pergadia, M. L., Khroyan, T. V., & Swan, G. E. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.018 · Cited by 95 · see citing works

In vivo Brain Imaging of Human Exposure to Nicotine and Tobacco

Sharma, A., & Brody, A. L. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-69248-5_6 · Cited by 88 · see citing works

Perspectives on MAO-B in Aging and Neurological Disease: Where Do We Go From Here?

Kumar, M. J., & Andersen, J. K. (2004) · Molecular Neurobiology · doi:10.1385/mn:30:1:077 · Cited by 92 · see citing works

Tobacco smoke exposure induces nicotine dependence in rats

Small, E., Shah, H. P., Davenport, J. J., Geier, J. E., Yavarovich, K. R., Yamada, H., Sabarinath, S., Derendorf, H., Pauly, J. R., Gold, M. S., et al. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1716-z · Cited by 85 · see citing works

The effect of smoking on MAOA promoter methylation in DNA prepared from lymphoblasts and whole blood

Philibert, R. A., Beach, S. R. H., Gunter, T. D., Brody, G. H., Madan, A., & Gerrard, M. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31031 · Cited by 80 · see citing works

Differential nicotinic regulation of the nigrostriatal and mesolimbic dopaminergic pathways: Implications for drug development

Janhunen, S. K., & Ahtee, L. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.09.008 · Cited by 81 · see citing works

Translational neuroimaging: positron emission tomography studies of monoamine oxidase

Fowler, J. S., Logan, J., Volkow, N. D., & Wang, G.-J. (2005) · Molecular Imaging and Biology · doi:10.1007/s11307-005-0016-1 · Cited by 81 · see citing works

Smoking cessation and depression: current knowledge and future directions

Wilhelm, K. A., Wedgwood, L., Niven, H., & KAY‐LAMBKIN, F. J. (2006) · Drug and Alcohol Review · doi:10.1080/09595230500459560 · Cited by 81 · see citing works

A mechanistic hypothesis of the factors that enhance vulnerability to nicotine use in females

O’Dell, L. E., & Torres, O. V. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.055 · Cited by 74 · see citing works

Going up in smoke: tobacco smoking is associated with worse treatment outcomes in mania

Berk, M., Ng, F., Wang, W. V., Tohen, M., Lubman, D. I., Vieta, E., & Dodd, S. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.01.018 · Cited by 72 · see citing works

Non-Nicotinic Therapies for Smoking Cessation

Siu, E. C. K., & Tyndale, R. F. (2007) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105354 · Cited by 69 · see citing works

Biomonitoring of inhaled complex mixtures – Ambient air, diesel exhaust and cigarette smoke

Scherer, G. (2005) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2005.05.007 · Cited by 68 · see citing works

Monoamine oxidase: radiotracer chemistry and human studies.

Fowler, J., Logan, J., Shumay, E., Alia-Klein, N., Wang, G.-J., & Volkow, N. (2015) · Journal of labelled compounds & radiopharmaceuticals · doi:10.1002/jlcr.3247 · Cited by 67 · see citing works

Analysis of monoamine oxidase enzymatic activity by reversed-phase high performance liquid chromatography and inhibition by β-carboline alkaloids occurring in foods and plants

Herraiz, T., & Chaparro, C. (2005) · Journal of Chromatography A · doi:10.1016/j.chroma.2005.12.009 · Cited by 59 · see citing works

Historical and current perspective on tobacco use and nicotine addiction

Dani, J. A., & Balfour, D. J. K. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.05.001 · Cited by 60 · see citing works

Examining the effect of smoking on suicidal ideation and attempts: triangulation of epidemiological approaches

Harrison, R., Munafo, M. R., Smith, G. D., & Wootton, R. E. (2020) · The British Journal of Psychiatry · doi:10.1192/bjp.2020.68 · Cited by 58 · see citing works

Persistent heavy smoking as risk factor for major depression (MD) incidence – Evidence from a longitudinal Canadian cohort of the National Population Health Survey

Khaled, S. M., Bulloch, A. G. M., Williams, J. V. A., Hill, J. C., Lavorato, D. H., & Patten, S. B. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.11.011 · Cited by 56 · see citing works

8.3 Imaging Dopamine’s Role in Drug Abuse and Addiction

Volkow, N. D., Fowler, J. S., Wang, G., Telang, F., & Baler, R. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195373035.003.0028 · Cited by 58 · see citing works

Suicidality in Opioid‐Dependent Subjects

Trémeau, F., Darreye, A., Staner, L., Corrêa, H., Weibel, H., Khidichian, F., & Macher, J. P. (2008) · American Journal on Addictions · doi:10.1080/10550490802020160 · Cited by 56 · see citing works

Monoamine oxidase (MAO) intron 13 polymorphism and platelet MAO-B activity in combat-related posttraumatic stress disorder

Pivac, N., Knežević, J., Kozarić‐Kovačić, D., Deželjin, M., Mustapić, M., Rak, D., Glavan, T. M., Pavelić, J., & Mück‐Šeler, D. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.01.017 · Cited by 56 · see citing works

Contribution of monoamine oxidase (MAO) inhibition to tobacco and alcohol addiction

van Amsterdam, J., Talhout, R., Vleeming, W., & Opperhuizen, A. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.06.010 · Cited by 56 · see citing works

A prospective study of the impact of smoking on outcomes in bipolar and schizoaffective disorder

Dodd, S., Brnabic, A. J. M., Berk, L., Fitzgerald, P. B., de Castella, A. R., Filia, S., Filia, K., Kelin, K., Smith, M., Montgomery, W. S., et al. (2010) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2009.12.001 · Cited by 55 · see citing works

The Relation between Nicotine Dependence and Suicide Attempts in the General Population

Yaworski, D., Robinson, J., Sareen, J., & Bolton, J. M. (2011) · The Canadian Journal of Psychiatry · doi:10.1177/070674371105600306 · Cited by 53 · see citing works

MAO-B Inhibitors Do Not Block In Vivo Flortaucipir([18F]-AV-1451) Binding

Hansen, A. K., Brooks, D. J., & Borghammer, P. (2018) · Molecular Imaging and Biology · doi:10.1007/s11307-017-1143-1 · Cited by 51 · see citing works

Electrochemical investigation into the redox activity of Fe(II)/Fe(III) in the presence of nicotine and possible relations to neurodegenerative diseases

Bridge, M. H., Williams, E., Lyons, M. E. G., Tipton, K. F., & Linert, W. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.05.007 · Cited by 52 · see citing works

Classifying smoking urges via machine learning

Dumortier, A., Beckjord, E. B., Shiffman, S. S., & Sejdić, E. (2016) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2016.09.016 · Cited by 47 · see citing works

Effects of high dose transdermal nicotine replacement in cigarette smokers

Hatsukami, D. K., Mooney, M. E., Murphy, S. E., LeSage, M. G., Babb, D. A., & Hecht, S. S. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.12.017 · Cited by 48 · see citing works

Methylphenidate Enhances the Abuse-Related Behavioral Effects of Nicotine in Rats: Intravenous Self-Administration, Drug Discrimination, and Locomotor Cross-Sensitization

Wooters, T. E., Neugebauer‎, N. M., Rush, C. R., & Bardo, M. T. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301477 · Cited by 46 · see citing works

Psychological distress is associated with tobacco smoking and quitting behaviour in the Australian population: evidence from National Cross-Sectional Surveys

Leung, J., Gartner, C., Dobson, A., Lucke, J., & Hall, W. (2011) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048674.2010.534070 · Cited by 46 · see citing works

New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?

Beard, E., Shahab, L., Cummings, D. M., Michie, S., & West, R. (2016) · CNS Drugs · doi:10.1007/s40263-016-0362-3 · Cited by 44 · see citing works

Tobacco particulate matter self‐administration in rats: differential effects of tobacco type

Brennan, K. A., Crowther, A., Putt, F., Roper, V., Waterhouse, U., & Truman, P. (2013) · Addiction Biology · doi:10.1111/adb.12099 · Cited by 43 · see citing works

Contribution of Monoamine Oxidase Inhibition to Tobacco Dependence: A Review of the Evidence

Hogg, R. C. (2015) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntv245 · Cited by 43 · see citing works

An updated patent review on monoamine oxidase (MAO) inhibitors

Guglielmi, P., Carradori, S., D’Agostino, I., Campestre, C., & Petzer, J. P. (2022) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2022.2083501 · Cited by 42 · see citing works

Monoamine Oxidase Inhibitors—Revisiting a Therapeutic Principle

Entzeroth, M., & Ratty, A. K. (2017) · Open Journal of Depression · doi:10.4236/ojd.2017.62004 · Cited by 42 · see citing works

Smoking Is Associated with Pain in All Body Regions, with Greatest Influence on Spinal Pain

Smuck, M. W., Schneider, B. J., Ehsanian, R., Martin, E. N., & Kao, M. J. (2019) · Pain Medicine · doi:10.1093/pm/pnz224 · Cited by 43 · see citing works

Monoamine Oxidase Inhibition for Tobacco Pharmacotherapy

George, T., & Weinberger, A. H. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100474 · Cited by 42 · see citing works

A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers☆

Weinberger, A. H., Reutenauer, E. L., Jatlow, P. I., O’Malley, S. S., Potenza, M. N., & George, T. P. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.10.009 · Cited by 41 · see citing works

Neuropharmacology of the Interoceptive Stimulus Properties of Nicotine

Wooters, T. E., Bevins, R. A., & Bardo, M. T. (2009) · Current Drug Abuse Reviews · doi:10.2174/1874473710902030243 · Cited by 40 · see citing works

Variations in gender ratios support the connection between smoking and Parkinson's disease

Morozova, N., O’Reilly, É. J., & Ascherio, A. (2008) · Movement Disorders · doi:10.1002/mds.22045 · Cited by 39 · see citing works

Tobacco and Psychiatric Dual Disorders

Graham, N. A., Frost-Pineda, K., & Gold, M. S. (2007) · Journal of Addictive Diseases · doi:10.1300/j069v26s01_02 · Cited by 38 · see citing works

MAO‐B knockout mice exhibit deficient habituation of locomotor activity but normal nicotine intake

Lee, M., Chen, K., Shih, J. C., & Hiroi, N. (2004) · Genes Brain & Behavior · doi:10.1111/j.1601-1848.2004.00074.x · Cited by 37 · see citing works

Exploring the Role of Monoamine Oxidase Activity in Aging and Alzheimer’s Disease

Rahman, M. S., Uddin, M. S., Rahman, M. A., Samsuzzaman, M., Behl, T., Hafeez, A., Perveen, A., Barreto, G. E., & Ashraf, G. M. (2021) · Current Pharmaceutical Design · doi:10.2174/1381612827666210612051713 · Cited by 36 · see citing works

Suicidal Ideation, Suicidal Plan and Suicidal Attempts Among Those with Major Depressive Disorder

Subramaniam, M., Abdin, E., Seow, E., Picco, L., Vaingankar, J. A., & Chong, S. A. (2014) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v43n8p412 · Cited by 35 · see citing works

Genetics and Drug Use as a Complex Phenotype

Lessov, C. N., Swan, G. E., Ring, H. Z., Khroyan, T. V., & Lerman, C. E. (2004) · Substance Use & Misuse · doi:10.1081/ja-200033202 · Cited by 35 · see citing works

Longitudinal association between tobacco use and the onset of depressive symptoms among Swedish adolescents: the Kupol cohort study

Raffetti, E., Donato, F., Forsell, Y., & Galanti, M. R. (2018) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-018-1237-6 · Cited by 34 · see citing works

The Role of Mesoaccumbens Dopamine in Nicotine Dependence

Balfour, D. J. K. (2015) · Current topics in behavioral neurosciences · doi:10.1007/978-3-319-13482-6_3 · Cited by 34 · see citing works

Reinforcing and neural activating effects of norharmane, a non-nicotine tobacco constituent, alone and in combination with nicotine

Arnold, M. M., Loughlin, S. E., Belluzzi, J. D., & Leslie, F. M. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.05.035 · Cited by 33 · see citing works

Comparison of the binding of the irreversible monoamine oxidase tracers, [11C]clorgyline and [11C]l-deprenyl in brain and peripheral organs in humans

Fowler, J. S., Logan, J., Wang, G., Volkow, N. D., Telang, F., Ding, Y., Shea, C. E., Garza, V., Xu, Y., Li, Z., et al. (2004) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2003.10.003 · Cited by 33 · see citing works

Smoking Cessation Pharmacotherapy—Nicotine and Non‐Nicotine Preparations

Frishman, W. H. (2007) · Preventive Cardiology · doi:10.1111/j.1520-037x.2007.05963.x · Cited by 33 · see citing works

Inhibition effects of Vernonia cinerea active compounds against cytochrome P450 2A6 and human monoamine oxidases, possible targets for reduction of tobacco dependence

Prasopthum, A., Pouyfung, P., Sarapusit, S., Srisook, E., & Rongnoparut, P. (2015) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2014.12.005 · Cited by 32 · see citing works

The effect of risky alcohol use and smoking on suicide risk: findings from the German MONICA/KORA-Augsburg Cohort Study

Schneider, B., Baumert, J. J., Schneider, A. L. C., Marten‐Mittag, B., Meisinger, C., Erazo, N., Hammer, G. P., & Ladwig, K. (2010) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-010-0287-y · Cited by 32 · see citing works

A case‐control study of Parkinson's disease and tobacco use: Gene‐tobacco interactions

Palma, G. D., Dick, F. D., Calzetti, S., SCOTT, N. W., Prescott, G. J., Osborne, A., Kingsbury, N., Mozzoni, P., Negrotti, A., Scaglioni, A., et al. (2010) · Movement Disorders · doi:10.1002/mds.22980 · Cited by 32 · see citing works

The serotonin 2A receptor gene in alcohol dependence and tobacco smoking

Polina, E. R., Contini, V., Hutz, M. H., & Bau, C. H. D. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.11.001 · Cited by 31 · see citing works

Age influences the effects of nicotine and monoamine oxidase inhibition on mood-related behaviors in rats

Villégier, A., Gallager, B., Heston, J. B., Belluzzi, J. D., & Leslie, F. M. (2010) · Psychopharmacology · doi:10.1007/s00213-009-1760-8 · Cited by 31 · see citing works

Markov model of smoking cessation

Killeen, P. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011277108 · Cited by 31 · see citing works

A review of monoamine oxidase (MAO) inhibitors in tobacco or tobacco smoke

Hong, S. W., Teesdale‐Spittle, P. H., Page, R., & Truman, P. (2022) · NeuroToxicology · doi:10.1016/j.neuro.2022.09.008 · Cited by 30 · see citing works

Monoamine oxidase inhibitory activity in tobacco smoke varies with tobacco type

Lewis, A. J., Truman, P., Hosking, M., & Miller, J. H. (2011) · Tobacco Control · doi:10.1136/tc.2010.040287 · Cited by 30 · see citing works

The lack of association between monoamine oxidase (MAO) intron 13 polymorphism and platelet MAO-B activity among men

Pivac, N., Knežević, J., Mustapić, M., Deželjin, M., Mück‐Šeler, D., Kozarić‐Kovačić, D., Balija, M., Glavan, T. M., & Pavelić, J. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.12.030 · Cited by 30 · see citing works

Genotype combinations for monoamine oxidase-B intron 13 polymorphism and dopamine D2 receptor TaqIB polymorphism are associated with ever-smoking status among men

Costa‐Mallen, P., Costa, L. G., & Checkoway, H. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.05.035 · Cited by 29 · see citing works

Enhanced smoking cue salience associated with depression severity in nicotine-dependent individuals: a preliminary fMRI study

Kushnir, V., Menon, M., Balducci, X. L., Selby, P. L., Busto, U. E., & Zawertailo, L. A. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000696 · Cited by 29 · see citing works

Neurobiology of Addiction

Koob, G. F., Kandel, D. B., Baler, R., & Volkow, N. D. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_29-1 · Cited by 31 · see citing works

The nicotine market: An attempt to estimate the nicotine intake from various sources and the total nicotine consumption in some countries

Fagerström, K. O. (2005) · Nicotine & Tobacco Research · doi:10.1080/14622200500124875 · Cited by 27 · see citing works

Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer’s disease and elderly controls after oral administration of sembragiline

Sturm, S., Forsberg, A., Navé, S., Stenkrona, P., Seneca, N. M., Varrone, A., Comley, R. A., Fazio, P., Jamois, C., Nakao, R., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3510-6 · Cited by 26 · see citing works

Monoamine oxidases and tobacco smoking

Berlin, I., & Anthenelli, R. M. (2001) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145701002188 · Cited by 146 · see citing works

Irreversible inhibition of monoamine oxidase by some components of cigarette smoke

Yu, P. H., & Boulton, A. A. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90446-2 · Cited by 122 · see citing works

A review of monoamine oxidase (MAO) inhibitors in tobacco or tobacco smoke

Hong, S. W., Teesdale‐Spittle, P. H., Page, R., & Truman, P. (2022) · NeuroToxicology · doi:10.1016/j.neuro.2022.09.008 · Cited by 30 · see citing works

Contribution of Monoamine Oxidase Inhibition to Tobacco Dependence: A Review of the Evidence

Hogg, R. C. (2015) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntv245 · Cited by 43 · see citing works

Inhibition of Monoamine Oxidase, Depletion of Lung Biogenic Amines by Cigarette Smoke and the Interaction of Some Components of This Smoke with Trace and Other Amines

Yu, P. H., Durden, D. A., Davis, B. A., & Boulton, A. A. (1988) · Humana Press eBooks · doi:10.1007/978-1-4612-4602-2_32 · Cited by 1 · see citing works